NorthWest Biotherapeutics Inc (NWBO): ""Where did you get this info concerning...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

NorthWest Biotherapeutics Inc (NWBO)

Reply Private New

Keep Last Read

Next 10 Prev Next

Send PM Follow Ignore

Followers	33
Posts	2666
Boards Moderated	0
Alias Born	10/28/2013

Re: koman post# 48077

Tuesday, 12/22/2015 11:00:56 PM

Tuesday, December 22, 2015 11:00:56 PM

""Where did you get this info concerning CLDX and their p3 Rintega trial?"
--------------------------------------------------------------------------

Feuerstein was making a comparison between a Celldex trial and the DCVax-L trial. As far as I know, the corresponding trial is this one:

"ACT IV— a Phase 3 Study of Rindopepimut in Patients with Newly Diagnosed EGFRvIII-Positive Glioblastoma"

This is the trial I was talking about. If that is the wrong trial, then my apologies.

To understand why I would make these claims for the ACT IV trial, please see post # 48136.

I missed Feuerstein's reply. Maybe that was for the best.

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent NWBO News

Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 12/26/2024 10:07:47 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2024 09:29:14 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2024 09:10:53 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/01/2024 09:24:13 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/03/2024 08:01:40 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 08:01:24 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2024 09:06:07 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2024 08:30:09 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 02:42:28 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/30/2024 11:49:38 PM
Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM

More NWBO News

InvestorsHub NewsWire

Basanite, Inc. to Open New Production and Distribution Facility in Northeast Ohio • BASA • Jan 2, 2025 8:28 AM

The Crypto Company Highlights Blockchain Training Alliance's Successes and Momentum for 2025 • CRCW • Dec 26, 2024 8:58 AM

Hertz Energy Provides Antimony and Critical Minerals Projects Update and Announces Financing • HZLIF • Dec 20, 2024 9:00 AM

North Bay Resources Announces Arrival of 42 Tons Gold Ore at Bishop Gold Mill, California • NBRI • Dec 20, 2024 9:00 AM

Consumer Automotive Finance Subsidiary Drago Knives Narrows Down Potential Partner to Manufacture Patented Throwing Knives • CAFI • Dec 20, 2024 9:00 AM

$ASNS - Is this the Next Big Cybersecurity Stock? How Actelis Networks is Revolutionizing Critical Infrastructure Protection • ASNS • Dec 20, 2024 8:50 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow